Erratum to: Provider management of equivocal cervical cancer screening results among underserved women, 2009–2011: follow-up of atypical squamous cells of undetermined significance

Context. Human papillomavirus (HPV) testing is widely used in cervical cancer screening in women; however, its efficiency in triaging women with atypical squamous cells of undetermined significance (ASC-US) needs to be validated. Objective. To evaluate the performance of HPV16/18 in the triage of women with ASC-US. Methods. Women presenting for routine cervical cancer screening had cervical specimens collected, with which both liquid-based cytology (LBC) and hrHPVs were examined; those with ASC-US cytology underwent colposcopy. HPV16/18 and 12 other types were tested with domestic hybridization capture and chemiluminescence signal amplification (DH3). Performance characteristics of HPV test (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) for identification of cervical intraepithelium neoplasma (CIN) grade 2 or worse (CIN2+), and CIN grade 3 or worse (CIN3+)) were determined using standard statistical tests. Results. 317 women with ASC-US were eligible for the study. HrHPV prevalence was 15.77% (50/317); HPV16/18 prevalence was 3.61% (20/317). Sensitivity and specificity of HPV16/18 for detection of CIN 2+ were 64.71% and 97% and 64.29% and 96.37% for detection of CIN 3+, respectively. The positive predictive values (PPVs) and negative predictive values (NPVs) of HPV16/18 were 55.00% and 97.98% for CIN2+ and 45.00% and 98.32% for CIN3+, respectively. Conclusion. HPV16/18 can be considered as an effective method to triage women with ASC-US as its good clinical performance. Trial Registration. This trial is registered with Henan Cancer Hospital Medical Ethics Committee on July 5, 2016 (http://www.anti-cancer.com.cn), with registry no.: 2016037.

Download Full-text

The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan

Asian Pacific Journal of Cancer Prevention ◽

10.31557/apjcp.2019.20.1.81 ◽

2019 ◽

Vol 20 (1) ◽

pp. 81-85 ◽

Cited By ~ 2

Author(s):

Hiroyuki Fujiwara ◽

Mitsuaki Suzuki ◽

Hiroyuki Morisawa ◽

Masaaki Sayama ◽

Kouzo Kimura

Keyword(s):

Cervical Cancer ◽

Human Papillomavirus ◽

Cancer Screening ◽

Cervical Cancer Screening ◽

Squamous Cells ◽

Human Papillomavirus Testing ◽

The Impact ◽

Undetermined Significance

Download Full-text

Three-year follow-up of women who participated in a prison cervical cancer screening intervention

PsycEXTRA Dataset ◽

10.1037/e508992013-086 ◽

2005 ◽

Author(s):

Ruth Elwood Martin ◽

Greg Hislop ◽

Veronika Moravan ◽

Garry Grams ◽

Betty Calam

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Cervical Cancer Screening

Download Full-text

Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations

Preventive Medicine ◽

10.1016/j.ypmed.2021.106770 ◽

2021 ◽

Vol 153 ◽

pp. 106770

Author(s):

Rebecca B. Perkins ◽

Rachael Adcock ◽

Vicki Benard ◽

Jack Cuzick ◽

Alan Waxman ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Cervical Cancer Screening ◽

Population Based ◽

Population Based Study

Download Full-text

Uptake and acceptability of human papillomavirus self-sampling in rural and remote Aboriginal communities: Evaluation of a nurse-led community engagement model

10.21203/rs.2.23841/v2 ◽

2020 ◽

Author(s):

Tegan Dutton ◽

Jo Marjoram ◽

Shellie Burgess ◽

Laurinne Campbell ◽

Anne Vail ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Clinical Outcomes ◽

Cervical Cancer Screening ◽

Rural And Remote ◽

Service Model ◽

Community Based ◽

Aboriginal Women ◽

Never Screened

Abstract Background: Aboriginal women experience disproportionately higher rates of cervical cancer mortality yet are less likely to participate in screening for early detection. This study sought to determine whether a community-based HPV self-sampling service model can effectively recruit never-screened and under-screened Aboriginal women to participate in cervical cancer screening; assess the clinical outcomes; and explore the acceptability of the model from the perspective of the participants.Methods: Aboriginal women aged 25-69 years of age were recruited from eight rural and remote communities in New South Wales, Australia to participate in HPV self-sampling via a community-based service model. Outcome measures were: number of women screened by HPV self-sampling, their prior cervical screening status (under-screened or never-screened), clinical outcomes and participation in follow-up pathways of care, and satisfaction with the service model.Results: In total, 215 women conducted a HPV self-sampling test and 200 evaluation surveys were completed. One-fifth of participants (n=46) were never-screened and one-third (n=69) were under-screened. Many were unsure of their screening status. Nine women were HPV 16/18 positive and eight had completed all follow up by the conclusion of the study. A further 30 women tested positive for a high risk type other than HPV 16/18 (HPV other), of which 14 had completed follow up at the conclusion of the study. Satisfaction with the HPV self-sampling kit, the process of self-sampling and the service model was high (>92% satisfied on all items). Many women had difficulty understanding their official HPV results and placed high importance on the nurse explaining it to them.Conclusions: A community-based service model that respects Aboriginal Women’s Business can effectively recruit under-screened and never-screened Aboriginal women to complete cervical cancer screening. Furthermore, this service model supports them to complete recommended follow-up care and engage with their local existing health services.

Download Full-text